Cargando…

Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC

The damage to normal pig bronchial mucosa caused by photodynamic therapy (PDT) using mTHPC and Photofrin as photosensitizers was evaluated. An endobronchial applicator was used to deliver the light with a linear diffuser and to measure the light fluence in situ. The applied fluences were varied, bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murrer, L H P, Hebeda, K M, Marijnissen, J P A, Star, W M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362296/ https://www.ncbi.nlm.nih.gov/pubmed/10360652 http://dx.doi.org/10.1038/sj.bjc.6690418

Ejemplares similares

Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts
por: Ris, H-B, et al.
Publicado: (1999)

mTHPC-Loaded Extracellular Vesicles Significantly Improve mTHPC Diffusion and Photodynamic Activity in Preclinical Models
por: Millard, Marie, et al.
Publicado: (2020)

Lipid‐DNAs as Solubilizers of mTHPC
por: Liu, Yun, et al.
Publicado: (2017)

Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).
por: Mikvy, P., et al.
Publicado: (1997)

EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy
por: Liu, Yanna, et al.
Publicado: (2020)

Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model
por: Rovers, J P, et al.
Publicado: (1999)

Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster.
por: Mlkvy, P., et al.
Publicado: (1996)

mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors
por: Millard, Marie, et al.
Publicado: (2018)

Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model
por: Wright, K E, et al.
Publicado: (2009)

Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo
por: Reshetov, Vadzim, et al.
Publicado: (2013)

Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines
por: Lange, Carsten, et al.
Publicado: (2019)

Photocytotoxicity of mTHPC (Temoporfin) Loaded Polymeric Micelles Mediated by Lipase Catalyzed Degradation
por: Hofman, Jan-Willem, et al.
Publicado: (2008)

Foscan® (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-α-mediated cytolytic activity
por: Coutier, S, et al.
Publicado: (1999)

A matched cohort comparison of mTHPC-mediated photodynamic therapy and trans-oral surgery of early stage oral cavity squamous cell cancer
por: Karakullukcu, Baris, et al.
Publicado: (2012)

Styrene Maleic Acid Copolymer-Based Micellar Formation of Temoporfin (SMA@ mTHPC) Behaves as A Nanoprobe for Tumor-Targeted Photodynamic Therapy with A Superior Safety
por: Fang, Jun, et al.
Publicado: (2021)

Uptake and localisation of mTHPC (Foscan®) and its(14)C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study
por: Blant, S Andrejevic, et al.
Publicado: (2002)

Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF
por: Golab, J, et al.
Publicado: (2000)

Evaluation for Synergistic Effects by Combinations of Photodynamic Therapy (PDT) with Temoporfin (mTHPC) and Pt(II) Complexes Carboplatin, Cisplatin or Oxaliplatin in a Set of Five Human Cancer Cell Lines
por: Lange, Carsten, et al.
Publicado: (2018)

Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC
por: Hornung, R, et al.
Publicado: (1999)

Photodynamic Therapy of Lung Cancer With Bronchial Artery Infusion of Photofrin
por: Okunaka, Tetsuya, et al.
Publicado: (1996)

Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics
por: Jones, H J, et al.
Publicado: (2003)

Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
por: Domagala, Antoni, et al.
Publicado: (2018)

Response of Photofrin-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light.
por: Foster, T. H., et al.
Publicado: (1996)

The In Vitro and In Vivo Anticancer Effect of Photomed for Photodynamic Therapy: Comparison with Photofrin and Radachlorin
por: Kim, Jieun, et al.
Publicado: (2023)

Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.
por: Krosl, G., et al.
Publicado: (1995)

Photofrin binds to procaspase-3 and mediates photodynamic treatment-triggered methionine oxidation and inactivation of procaspase-3
por: Hsieh, Y-J, et al.
Publicado: (2012)

Curative effect of the recent photofrin photodynamic adjuvant treatment on young patients with advanced colorectal cancer
por: SUN, BO, et al.
Publicado: (2016)

TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy
por: Lee, S Y, et al.
Publicado: (2010)

Cooperative Clinical Trial of Photodynamic Therapy for Early Gastric Cancer With Photofrin Injection(®) and YAG-OPO Laser
por: Mimura, Seishiro, et al.
Publicado: (1998)

Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
por: Gibson, S. L., et al.
Publicado: (1990)

Half-Fluence, Half-Dose Photodynamic Therapy: Less Direct Damage but More Inflammation?
por: Desmettre, Thomas, et al.
Publicado: (2023)

Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy
por: Ngo, Wei Kiong, et al.
Publicado: (2020)

Novel After‐loading Interstitial Photodynamic Therapy of Canine Transmissible Sarcoma with Photofrin II and Excimer Dye Laser
por: Hashimoto, Yasuo, et al.
Publicado: (1995)

Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II.
por: Grosjean, P., et al.
Publicado: (1998)

Interstitial photodynamic therapy in a rat liver metastasis model.
por: van Hillegersberg, R., et al.
Publicado: (1992)

Distribution of Photofrin between tumour cells and tumour associated macrophages.
por: Korbelik, M., et al.
Publicado: (1991)

A Comparison of Singlet Oxygen Explicit Dosimetry (SOED) and Singlet Oxygen Luminescence Dosimetry (SOLD) for Photofrin-Mediated Photodynamic Therapy
por: Kim, Michele M., et al.
Publicado: (2016)

Irradiance, Photofrin(®) Dose and Initial Tumor Volume are Key Predictors of Response to Interstitial Photodynamic Therapy of Locally Advanced Cancers in Translational Models
por: Oakley, Emily, et al.
Publicado: (2020)

Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD)
por: Fingar, V H, et al.
Publicado: (1999)

Photofrin accumulation in malignant and host cell populations of various tumours.
por: Korbelik, M., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_iknb7jupnq7ca4mkll1k7h3gm0